Joshua D Grill

Title(s)Associate Professor, Neurobiology & Behavior
Address1001 Health Sciences Road
Irvine CA 92697-3950
Phone(949) 824-5905
vCardDownload vCard
    Other Positions
    Title(s)Professor, Psychiatry and Human Behavior


    Collapse Research 
    Collapse Research Activities and Funding
    Training in Translational ADRD Neuroscience (TITAN)
    NIH T32AG073088Sep 1, 2021 - Aug 31, 2026
    Role: Principal Investigator
    Institute on Methods and Protocols for Advancement of Clinical Trials in ADRD (NIA/AA IMPACT-AD) Course
    NIH U13AG067696Jun 1, 2020 - May 31, 2025
    Role: Co-Principal Investigator
    Effects of Alzheimer's disease clinical trial study partners
    NIH RF1AG059407May 15, 2018 - Apr 30, 2022
    Role: Principal Investigator
    Effects of Alzheimer's disease clinical trial study partners
    NIH/NIA R01AG059407May 15, 2018 - Feb 28, 2022
    Role: Principal Investigator
    The study partner requirement in preclinical Alzheimers disease trials
    NIH R21AG056931Sep 15, 2017 - May 31, 2020
    Role: Principal Investigator
    UCLA NEXT Collaboration Site
    NIH U10NS077355Sep 30, 2011 - Jun 30, 2020
    Role: Co-Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Disclosure of individual research results at federally funded Alzheimer's Disease Research Centers. Alzheimers Dement (N Y). 2021; 7(1):e12213. Roberts JS, Ferber R, Blacker D, Rumbaugh M, Grill JD, Advisory Group on Risk Evidence Education for Dementia (AGREED). PMID: 34692986; PMCID: PMC8515553.
      View in: PubMed   Mentions:
    2. Symptoms of obstructive sleep apnea are associated with less frequent exercise and worse subjective cognitive function across adulthood. Sleep. 2021 Oct 04. Chappel-Farley MG, Mander BA, Neikrug AB, Stehli A, Nan B, Grill JD, Yassa MA, Benca RM. PMID: 34604910.
      View in: PubMed   Mentions:    Fields:    
    3. The approval of Aduhelm risks eroding public trust in Alzheimer research and the FDA. Nat Rev Neurol. 2021 Sep; 17(9):523-524. Karlawish J, Grill JD. PMID: 34267383.
      View in: PubMed   Mentions:    Fields:    
    4. On the design of early-phase Alzheimer's disease clinical trials with cerebrospinal fluid tau outcomes. Clin Trials. 2021 Jul 29; 17407745211034497. Nuño MM, Grill JD, Gillen DL, Alzheimer’s Disease Neuroimaging Initiative. PMID: 34325548.
      View in: PubMed   Mentions:    Fields:    
    5. Asian Americans and Pacific Islanders' perspectives on participating in the CARE recruitment research registry for Alzheimer's disease and related dementias, aging, and caregiving research. Alzheimers Dement (N Y). 2021; 7(1):e12195. Ta Park V, Grill JD, Zhu J, Nguyen K, Nam B, Tsoh J, Kanaya A, Vuong Q, Bang J, Nguyen NCY, Cho IH, Gallagher-Thompson D, Hinton L, Meyer OL. PMID: 34295961.
      View in: PubMed   Mentions:
    6. Reasons for undergoing amyloid imaging among cognitively unimpaired older adults. Ann Clin Transl Neurol. 2021 08; 8(8):1646-1655. Ryan MM, Gillen DL, Grill JD. PMID: 34227249; PMCID: PMC8351390.
      View in: PubMed   Mentions:    Fields:    
    7. Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial. JAMA Netw Open. 2021 Jul 01; 4(7):e2114364. Raman R, Quiroz YT, Langford O, Choi J, Ritchie M, Baumgartner M, Rentz D, Aggarwal NT, Aisen P, Sperling R, Grill JD. PMID: 34228129.
      View in: PubMed   Mentions: 1     Fields:    
    8. Implications of FDA Approval of a First Disease-Modifying Therapy for a Neurodegenerative Disease on the Design of Subsequent Clinical Trials. Neurology. 2021 09 07; 97(10):496-500. Grill JD, Karlawish J. PMID: 34088880; PMCID: PMC8448555.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Using Direct-to-Consumer Genetic Testing Results to Accelerate Alzheimer Disease Clinical Trial Recruitment. Alzheimer Dis Assoc Disord. 2021 Apr-Jun 01; 35(2):141-147. Ryan MM, Cox CG, Witbracht M, Hoang D, Gillen DL, Grill JD. PMID: 33060367; PMCID: PMC8044253.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Pilot study of an Alzheimer's disease risk assessment program in a primary care setting. Alzheimers Dement (Amst). 2021; 13(1):e12157. Korthauer LE, Denby C, Molina D, Wanjiku J, Daiello LA, Drake JD, Grill JD, Ott BR. PMID: 33665347; PMCID: PMC7896638.
      View in: PubMed   Mentions:
    11. Research Attitudes Questionnaire scores predict Alzheimer's disease clinical trial dropout. Clin Trials. 2021 04; 18(2):237-244. Stites SD, Turner RS, Gill J, Gurian A, Karlawish J, Grill JD, Alzheimer’s Disease Cooperative Study. PMID: 33426901; PMCID: PMC8009810.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Recruitment and retention of participant and study partner dyads in two multinational Alzheimer's disease registration trials. Alzheimers Res Ther. 2021 01 08; 13(1):16. Bernstein OM, Grill JD, Gillen DL. PMID: 33419457; PMCID: PMC7791680.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    13. Direct Mail Recruitment to a Potential Participant Registry. Alzheimer Dis Assoc Disord. 2021 Jan-Mar 01; 35(1):80-83. Gombosev A, Salazar CR, Hoang D, Cox CG, Gillen DL, Grill JD. PMID: 31821186; PMCID: PMC7280074.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. Short-term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive Impairment. JAMA Neurol. 2020 12 01; 77(12):1504-1513. Grill JD, Raman R, Ernstrom K, Sultzer DL, Burns JM, Donohue MC, Johnson KA, Aisen PS, Sperling RA, Karlawish J, A4 Study Team . PMID: 32777010.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    15. Education and Message Framing Increase Willingness to Undergo Research Lumbar Puncture: A Randomized Controlled Trial. Front Med (Lausanne). 2020; 7:493. Witbracht MG, Bernstein OM, Lin V, Salazar CR, Sajjadi SA, Hoang D, Cox CG, Gillen DL, Grill JD. PMID: 33043024.
      View in: PubMed   Mentions: 1  
    16. Racial and ethnic differences in older adults' willingness to be contacted about Alzheimer's disease research participation. Alzheimers Dement (N Y). 2020; 6(1):e12023. Salazar CR, Hoang D, Gillen DL, Grill JD. PMID: 32399482.
      View in: PubMed   Mentions: 4  
    17. Study partner types and prediction of cognitive performance: implications to preclinical Alzheimer's trials. Alzheimers Res Ther. 2019 11 27; 11(1):92. Nuño MM, Gillen DL, Grill JD, Alzheimer’s Disease Cooperative Study . PMID: 31775871.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. Participant and study partner prediction and identification of cognitive impairment in preclinical Alzheimer's disease: study partner vs. participant accuracy. Alzheimers Res Ther. 2019 10 18; 11(1):85. Ryan MM, Grill JD, Gillen DL, Alzheimer’s Disease Neuroimaging Initiative . PMID: 31627738.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    19. Retention of Alzheimer Disease Research Participants. Alzheimer Dis Assoc Disord. 2019 Oct-Dec; 33(4):299-306. Grill JD, Kwon J, Teylan MA, Pierce A, Vidoni ED, Burns JM, Lindauer A, Quinn J, Kaye J, Gillen DL, Nan B. PMID: 31567302.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    20. Response to "Avoiding Methodological Bias in Studies of Amyloid Imaging Results Disclosure". Alzheimers Res Ther. 2019 06 04; 11(1):51. Grill JD, Cox CG, Harkins K, Karlawish J. PMID: 31159857.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Which MCI Patients Should be Included in Prodromal Alzheimer Disease Clinical Trials? Alzheimer Dis Assoc Disord. 2019 Apr-Jun; 33(2):104-112. Grill JD, Nuño MM, Gillen DL, Alzheimer’s Disease Neuroimaging Initiative . PMID: 30958413.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    22. Recruiting the Oldest-old for Clinical Research. Alzheimer Dis Assoc Disord. 2019 Apr-Jun; 33(2):160-162. Melikyan ZA, Greenia DE, Corrada MM, Hester MM, Kawas CH, Grill JD. PMID: 29734262.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    23. Reactions to learning a "not elevated" amyloid PET result in a preclinical Alzheimer's disease trial. Alzheimers Res Ther. 2018 12 22; 10(1):125. Grill JD, Cox CG, Harkins K, Karlawish J. PMID: 30579361.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    24. A Preliminary Study of Clinical Trial Enrollment Decisions Among People With Mild Cognitive Impairment and Their Study Partners. Am J Geriatr Psychiatry. 2019 03; 27(3):322-332. Cox CG, Ryan B A MM, Gillen DL, Grill JD. PMID: 30522811.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    25. Participant Satisfaction With Learning Alzheimer Disease Clinical Trial Results. Alzheimer Dis Assoc Disord. 2018 Oct-Dec; 32(4):366-368. Pierce AL, Cox CG, Nguyen HT, Hoang D, Witbracht M, Gillen DL, Grill JD. PMID: 29683808.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    26. Study partners: essential collaborators in discovering treatments for Alzheimer's disease. Alzheimers Res Ther. 2018 09 27; 10(1):101. Largent EA, Karlawish J, Grill JD. PMID: 30261910.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    27. Changes in regional cerebral blood flow associated with a 45 day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer's disease: Results of a randomized, double-blinded, pilot study. Exp Gerontol. 2018 10 01; 111:118-121. Torosyan N, Sethanandha C, Grill JD, Dilley ML, Lee J, Cummings JL, Ossinalde C, Silverman DH. PMID: 30006299.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    28. Constructing a Local Potential Participant Registry to Improve Alzheimer's Disease Clinical Research Recruitment. J Alzheimers Dis. 2018; 63(3):1055-1063. Grill JD, Hoang D, Gillen DL, Cox CG, Gombosev A, Klein K, O'Leary S, Witbracht M, Pierce A. PMID: 29710723.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    29. Study partners should be required in preclinical Alzheimer's disease trials. Alzheimers Res Ther. 2017 Dec 06; 9(1):93. Grill JD, Karlawish J. PMID: 29212555.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    30. Attitudes toward clinical trials across the Alzheimer's disease spectrum. Alzheimers Res Ther. 2017 Oct 04; 9(1):81. Nuño MM, Gillen DL, Dosanjh KK, Brook J, Elashoff D, Ringman JM, Grill JD. PMID: 28978335.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    31. Recruiting to preclinical Alzheimer's disease clinical trials through registries. Alzheimers Dement (N Y). 2017 Jun; 3(2):205-212. Grill JD. PMID: 28439532.
      View in: PubMed   Mentions: 8  
    32. Communicating mild cognitive impairment diagnoses with and without amyloid imaging. Alzheimers Res Ther. 2017 May 04; 9(1):35. Grill JD, Apostolova LG, Bullain S, Burns JM, Cox CG, Dick M, Hartley D, Kawas C, Kremen S, Lingler J, Lopez OL, Mapstone M, Pierce A, Rabinovici G, Roberts JS, Sajjadi SA, Teng E, Karlawish J. PMID: 28472970.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    33. Willingness to Be a Brain Donor: A Survey of Research Volunteers From 4 Racial/Ethnic Groups. Alzheimer Dis Assoc Disord. 2017 Apr-Jun; 31(2):135-140. Boise L, Hinton L, Rosen HJ, Ruhl MC, Dodge H, Mattek N, Albert M, Denny A, Grill JD, Hughes T, Lingler JH, Morhardt D, Parfitt F, Peterson-Hazan S, Pop V, Rose T, Shah RC. PMID: 27779492.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    34. Patient and caregiver reactions to clinical amyloid imaging. Alzheimers Dement. 2017 Aug; 13(8):924-932. Grill JD, Cox CG, Kremen S, Mendez MF, Teng E, Shapira J, Ringman JM, Apostolova LG. PMID: 28174068.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    35. Optimizing Effect Sizes With Imaging Enrichment and Outcome Choices for Mild Alzheimer Disease Clinical Trials. Alzheimer Dis Assoc Disord. 2017 Jan-Mar; 31(1):19-26. Chang TS, Teng E, Elashoff D, Grill JD, Alzheimer’s Disease Neuroimaging Initiative . PMID: 27196535.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    36. Attitudes toward Potential Participant Registries. J Alzheimers Dis. 2017; 56(3):939-946. Grill JD, Holbrook A, Pierce A, Hoang D, Gillen DL. PMID: 28106553.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    37. Critical review of the Appropriate Use Criteria for amyloid imaging: Effect on diagnosis and patient care. Alzheimers Dement (Amst). 2016; 5:15-22. Apostolova LG, Haider JM, Goukasian N, Rabinovici GD, Chételat G, Ringman JM, Kremen S, Grill JD, Restrepo L, Mendez MF, Silverman DH. PMID: 28054024.
      View in: PubMed   Mentions: 8  
    38. African Americans are less likely to enroll in preclinical Alzheimer's disease clinical trials. Alzheimers Dement (N Y). 2017 Jan; 3(1):57-64. Zhou Y, Elashoff D, Kremen S, Teng E, Karlawish J, Grill JD. PMID: 29067319.
      View in: PubMed   Mentions: 25  
    39. Participant-Informant Relationships Affect Quality of Life Ratings in Incipient and Clinical Alzheimer Disease. Am J Geriatr Psychiatry. 2017 Mar; 25(3):297-307. Lin A, Brook J, Grill JD, Teng E. PMID: 27818119.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    40. Disclosure of amyloid status is not a barrier to recruitment in preclinical Alzheimer's disease clinical trials. Neurobiol Aging. 2016 Mar; 39:147-53. Grill JD, Zhou Y, Elashoff D, Karlawish J. PMID: 26923411.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    41. Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical Trial. JAMA Neurol. 2015 Nov; 72(11):1324-33. Coric V, Salloway S, van Dyck CH, Dubois B, Andreasen N, Brody M, Curtis C, Soininen H, Thein S, Shiovitz T, Pilcher G, Ferris S, Colby S, Kerselaers W, Dockens R, Soares H, Kaplita S, Luo F, Pachai C, Bracoud L, Mintun M, Grill JD, Marek K, Seibyl J, Cedarbaum JM, Albright C, Feldman HH, Berman RM. PMID: 26414022.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCTClinical Trials
    42. Does Alzheimer Disease Pathologic Change Underlie Subjective Cognitive Complaints? Alzheimer Dis Assoc Disord. 2015 Oct-Dec; 29(4):350-2. Grill JD, Vinters HV, Monsell SE. PMID: 25973910.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    43. Consider the Source: The Implications of Informant Type on Outcome Assessments. Alzheimer Dis Assoc Disord. 2015 Oct-Dec; 29(4):364. Grill JD, Karlawish J. PMID: 26485500.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    44. A survey of attitudes toward clinical trials and genetic disclosure in autosomal dominant Alzheimer's disease. Alzheimers Res Ther. 2015; 7(1):50. Grill JD, Bateman RJ, Buckles V, Oliver A, Morris JC, Masters CL, Klunk WE, Ringman JM, Dominantly Inherited Alzheimer’s Network . PMID: 26203303.
      View in: PubMed   Mentions: 4     Fields:    
    45. Frequency and impact of informant replacement in Alzheimer disease research. Alzheimer Dis Assoc Disord. 2015 Jul-Sep; 29(3):242-8. Grill JD, Zhou Y, Karlawish J, Elashoff D. PMID: 25551863.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    46. Alzheimer's disease progression by geographical region in a clinical trial setting. Alzheimers Res Ther. 2015; 7(1):43. Henley DB, Dowsett SA, Chen YF, Liu-Seifert H, Grill JD, Doody RS, Aisen P, Raman R, Miller DS, Hake AM, Cummings J. PMID: 26120369.
      View in: PubMed   Mentions: 15     Fields:    
    47. Comparing recruitment, retention, and safety reporting among geographic regions in multinational Alzheimer's disease clinical trials. Alzheimers Res Ther. 2015; 7(1):39. Grill JD, Raman R, Ernstrom K, Aisen P, Dowsett SA, Chen YF, Liu-Seifert H, Hake AM, Miller DS, Doody RS, Henley DB, Cummings JL. PMID: 26120368.
      View in: PubMed   Mentions: 13     Fields:    
    48. Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants. Alzheimers Res Ther. 2015; 7(1):26. Harkins K, Sankar P, Sperling R, Grill JD, Green RC, Johnson KA, Healy M, Karlawish J. PMID: 25969699.
      View in: PubMed   Mentions: 34     Fields:    
    49. Why are spousal caregivers more prevalent than nonspousal caregivers as study partners in AD dementia clinical trials? Alzheimer Dis Assoc Disord. 2015 Jan-Mar; 29(1):70-4. Cary MS, Rubright JD, Grill JD, Karlawish J. PMID: 24805971.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    50. Longitudinal declines in instrumental activities of daily living in stable and progressive mild cognitive impairment. Dement Geriatr Cogn Disord. 2015; 39(1-2):12-24. Hsiao JJ, Lu PH, Grill JD, Teng E. PMID: 25300404.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    51. Does study partner type impact the rate of Alzheimer's disease progression? J Alzheimers Dis. 2014; 38(3):507-14. Grill JD, Zhou Y, Karlawish J, Elashoff D. PMID: 23985417.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    52. Facilitating Alzheimer disease research recruitment. Alzheimer Dis Assoc Disord. 2014 Jan-Mar; 28(1):1-8. Grill JD, Galvin JE. PMID: 24322484; PMCID: PMC3945167.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    53. Choosing Alzheimer's disease prevention clinical trial populations. Neurobiol Aging. 2014 Mar; 35(3):466-71. Grill JD, Monsell SE. PMID: 24119546.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    54. The impact of the availability of prevention studies on the desire to undergo predictive testing in persons at risk for autosomal dominant Alzheimer's disease. Contemp Clin Trials. 2013 Sep; 36(1):256-62. Hooper M, Grill JD, Rodriguez-Agudelo Y, Medina LD, Fox M, Alvarez-Retuerto AI, Wharton D, Brook J, Ringman JM. PMID: 23876673.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    55. Multilocus genetic profiling to empower drug trials and predict brain atrophy. Neuroimage Clin. 2013; 2:827-35. Kohannim O, Hua X, Rajagopalan P, Hibar DP, Jahanshad N, Grill JD, Apostolova LG, Toga AW, Jack CR, Weiner MW, Thompson PM, Alzheimer's Disease Neuroimaging Initiative . PMID: 24179834.
      View in: PubMed   Mentions: 17     Fields:    
    56. Should we disclose amyloid imaging results to cognitively normal individuals? Neurodegener Dis Manag. 2013 Feb; 3(1):43-51. Grill JD, Johnson DK, Burns JM. PMID: 25285157.
      View in: PubMed   Mentions: 16     Fields:    
    57. Effect of study partner on the conduct of Alzheimer disease clinical trials. Neurology. 2013 Jan 15; 80(3):282-8. Grill JD, Raman R, Ernstrom K, Aisen P, Karlawish J. PMID: 23255824.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    58. Risk disclosure and preclinical Alzheimer's disease clinical trial enrollment. Alzheimers Dement. 2013 May; 9(3):356-359.e1. Grill JD, Karlawish J, Elashoff D, Vickrey BG. PMID: 23141383.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    59. Are patients whose study partners are spouses more likely to be eligible for Alzheimer's disease clinical trials? Dement Geriatr Cogn Disord. 2012; 33(5):334-40. Grill JD, Monsell S, Karlawish J. PMID: 22759982.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    60. Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative. Neurobiol Aging. 2013 Jan; 34(1):62-72. Grill JD, Di L, Lu PH, Lee C, Ringman J, Apostolova LG, Chow N, Kohannim O, Cummings JL, Thompson PM, Elashoff D, Alzheimer's Disease Neuroimaging Initiative . PMID: 22503160.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    61. Should persons with autosomal dominant AD be included in clinical trials? Alzheimers Res Ther. 2011 May 23; 3(3):18. Grill JD, Ringman JM. PMID: 21609419.
      View in: PubMed   Mentions: 1     Fields:    
    62. Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials. Alzheimers Res Ther. 2010 Dec 21; 2(6):34. Hanna RF, Ward TJ, Chow DS, Lagana SM, Moreira RK, Emond JC, Weintraub JL, Prince MR, Grill JD, Karlawish J. PMID: 21172069; PMCID: PMC3031880.
      View in: PubMed   Mentions: 57     Fields:    
    63. Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Prevention trials in persons at risk for dominantly inherited Alzheimer's disease: opportunities and challenges. Alzheimers Dement. 2009 Mar; 5(2):166-71. Ringman JM, Grill J, Rodriguez-Agudelo Y, Chavez M, Xiong C. PMID: 19328453.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    Joshua's Networks
    Concepts (151)
    Derived automatically from this person's publications.
    _
    Co-Authors (28)
    People in Profiles who have published with this person.
    _
    Similar People (59)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _